Document And Entity Information
Document And Entity Information | Mar. 19, 2024 |
Document Information [Line Items] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Mar. 19, 2024 |
Entity Registrant Name | Tempest Therapeutics, Inc. |
Entity Central Index Key | 0001544227 |
Entity Emerging Growth Company | false |
Entity File Number | 001-35890 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 45-1472564 |
Entity Address, Address Line One | 2000 Sierra Point Parkway, Suite 400 |
Entity Address, City or Town | Brisbane |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94005 |
City Area Code | (415) |
Local Phone Number | 798-8589 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Common Stock [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | Common Stock, $0.001 par value |
Trading Symbol | TPST |
Security Exchange Name | NASDAQ |
Series A Junior Participating Preferred Purchase Rights [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | Series A Junior Participating Preferred Purchase Rights |
No Trading Symbol Flag | true |
Security Exchange Name | NASDAQ |